tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Zai Lab Ltd

ZLAB
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
20.590USD
+0.260+1.28%
์ข…๊ฐ€ย 05/15, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
2.33B์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ Zai Lab Ltd ํšŒ์‚ฌ

Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.

Zai Lab Ltd ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ ZLAB
ํšŒ์‚ฌ ์ด๋ฆ„Zai Lab Ltd
์ƒ์žฅ์ผSep 28, 2020
CEODu (Ying)
์ง์› ์ˆ˜1869
์œ ํ˜•Depository Receipt
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒSep 28
์ฃผ์†ŒBuilding B, 899 Halei Road, Pudong
๋„์‹œSHANGHAI
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€China
์šฐํŽธ ๋ฒˆํ˜ธ201203
์ „ํ™”862161632588
์›น์‚ฌ์ดํŠธhttps://www.zailaboratory.com/
์ข…๋ชฉ ์ฝ”๋“œ ZLAB
์ƒ์žฅ์ผSep 28, 2020
CEODu (Ying)

Zai Lab Ltd์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
117.60K
+22.60%
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+10.86%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-8.50%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
19.15K
-4.46%
Dr. Ying (Samantha) Du, Ph.D.
Dr. Ying (Samantha) Du, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--
Mr. Peter Karl Wirth, J.D.
Mr. Peter Karl Wirth, J.D.
Independent Director
Independent Director
--
--
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Mr. Leon Oliver (Lonnie) Moulder, Jr.
Independent Director
Independent Director
--
--
Mr. Frazor Titus Edmondson, J.D.
Mr. Frazor Titus Edmondson, J.D.
Company Secretary, Chief Legal Officer
Company Secretary, Chief Legal Officer
--
--
Mr. Scott W. Morrison, CPA
Mr. Scott W. Morrison, CPA
Independent Director
Independent Director
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Joshua L. Smiley
Mr. Joshua L. Smiley
President, Chief Operating Officer
President, Chief Operating Officer
117.60K
+22.60%
Dr. John David Diekman, Ph.D.
Dr. John David Diekman, Ph.D.
Lead Independent Director
Lead Independent Director
99.77K
+10.86%
Mr. William David (Bill) Lis
Mr. William David (Bill) Lis
Independent Director
Independent Director
35.11K
-8.50%
Dr. Yajing Chen, Ph.D.
Dr. Yajing Chen, Ph.D.
Chief Financial Officer
Chief Financial Officer
19.15K
-4.46%
Dr. Ying (Samantha) Du, Ph.D.
Dr. Ying (Samantha) Du, Ph.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Ms. Leung (Nisa Bernice) Wing-Yu
Ms. Leung (Nisa Bernice) Wing-Yu
Independent Director
Independent Director
--
--

์ˆ˜์ต ๋ถ„์„

ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Apr 6
ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
์‚ฌ์—…๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
ZEJULA
189.04M
41.35%
VYVGART
94.20M
20.60%
NUZYRA
60.84M
13.31%
Optune
48.33M
10.57%
QINLOCK
35.61M
7.79%
๊ธฐํƒ€
29.17M
6.38%
์ง€์—ญ๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
China (Mainland)
460.16M
0.00%
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
์‚ฌ์—…๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
ZEJULA
189.04M
41.35%
VYVGART
94.20M
20.60%
NUZYRA
60.84M
13.31%
Optune
48.33M
10.57%
QINLOCK
35.61M
7.79%
๊ธฐํƒ€
29.17M
6.38%

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Thu, May 14
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Thu, May 14
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
RTW Investments L.P.
6.19%
RA Capital Management, LP
5.11%
Norges Bank Investment Management (NBIM)
3.42%
Frazier Life Sciences Management, L.P.
1.69%
ClearBridge Investments, LLC
1.61%
๊ธฐํƒ€
81.97%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
RTW Investments L.P.
6.19%
RA Capital Management, LP
5.11%
Norges Bank Investment Management (NBIM)
3.42%
Frazier Life Sciences Management, L.P.
1.69%
ClearBridge Investments, LLC
1.61%
๊ธฐํƒ€
81.97%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Investment Advisor/Hedge Fund
11.71%
Investment Advisor
5.60%
Venture Capital
5.36%
Hedge Fund
4.22%
Sovereign Wealth Fund
3.42%
Individual Investor
1.91%
Private Equity
1.69%
Research Firm
1.50%
Pension Fund
0.05%
๊ธฐํƒ€
64.54%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Apr 1
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Apr 1
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2026Q4
280
37.42M
42.38%
--
2026Q1
352
37.82M
33.67%
-10.78M
2025Q4
370
44.73M
39.84%
-12.84M
2025Q3
372
46.61M
41.70%
-15.37M
2025Q2
394
60.58M
54.15%
-11.96M
2025Q1
453
59.51M
53.68%
-14.18M
2024Q4
446
60.80M
55.47%
-4.29M
2024Q3
439
51.45M
51.99%
-10.14M
2024Q2
454
47.04M
47.66%
-14.67M
2024Q1
465
46.22M
46.47%
-13.77M
๋” ๋ณด๊ธฐ

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
RTW Investments L.P.
6.96M
6.14%
+4.67M
+203.71%
Dec 31, 2025
Norges Bank Investment Management (NBIM)
3.84M
3.39%
+3.84M
--
Dec 31, 2025
Frazier Life Sciences Management, L.P.
1.90M
1.68%
+275.00K
+16.90%
Dec 31, 2025
ClearBridge Investments, LLC
1.81M
1.59%
-1.71M
-48.63%
Dec 31, 2025
Citadel Advisors LLC
1.69M
1.49%
+700.80K
+71.00%
Dec 31, 2025
Fidelity Management & Research Company LLC
1.44M
1.27%
-2.84M
-66.32%
Dec 31, 2025
Baron Capital Management, Inc.
1.42M
1.25%
+46.76K
+3.41%
Dec 31, 2025
Adar1 Capital Management LLC
1.25M
1.1%
+377.74K
+43.48%
Dec 31, 2025
Du (Ying Samantha)
1.06M
0.94%
+145.74K
+15.88%
Mar 11, 2026
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Dec 6
์ด๋ฆ„
๋น„์œจ
Tema Oncology ETF
1.67%
ALPS Medical Breakthroughs ETF
1.19%
Virtus LifeSci Biotech Products ETF
0.97%
Invesco Golden Dragon China ETF
0.58%
National Security Emerging Markets Index ETF
0.39%
iShares Biotechnology ETF
0.18%
Capital Group New Geography Equity ETF
0.15%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.12%
ActivePassive International Equity ETF
0.03%
๋” ๋ณด๊ธฐ
Tema Oncology ETF
๋น„์œจ1.67%
ALPS Medical Breakthroughs ETF
๋น„์œจ1.19%
Virtus LifeSci Biotech Products ETF
๋น„์œจ0.97%
Invesco Golden Dragon China ETF
๋น„์œจ0.58%
National Security Emerging Markets Index ETF
๋น„์œจ0.39%
iShares Biotechnology ETF
๋น„์œจ0.18%
Capital Group New Geography Equity ETF
๋น„์œจ0.15%
ProShares Ultra Nasdaq Biotechnology
๋น„์œจ0.12%
Invesco Nasdaq Biotechnology ETF
๋น„์œจ0.12%
ActivePassive International Equity ETF
๋น„์œจ0.03%

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
KeyAI
๎™